I'm guessing you have a situation where vast numbers of people are not getting some treatment, you choose a manageable small subset to study, and only treat half of those. What's wrong with that? The alternative is not treating everybody in the continent, it's studying something else and treating nobody. Why would a researcher have the money and resources to treat everyone? (It does seem fair to offer the treatment to everyone involved in your trial after it's over.)
